Navigation Links
DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
Date:8/6/2012

CUPERTINO, Calif., Aug. 6, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended June 30, 2012. Total revenues were $4.8 million for the three months ended June 30, 2012 as compared to $7.8 million for the three months ended June 30, 2011.  Net loss for the three months ended June 30, 2012 was $4.3 million, compared to a net loss of $5.2 million for the same period in 2011.(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

At June 30, 2012, we had cash and investments of $23.7 million, compared to cash and investments of $26.4 million at March 31, 2012 and $30.8 million at December 31, 2011.  We have no debt obligations, other than normal liabilities associated with running our business."Based on our recent pre-NDA communications with the FDA, we intend to submit a new drug application for POSIDUR in late 2012 or early 2013," stated James E. Brown, D.V.M., President and CEO of DURECT.  "We are also pleased that Pfizer continues to move forward with their efforts to prepare for an FDA interaction later this year with respect to REMOXY and that Zogenix has commenced a Phase I clinical trial for Relday."

Update of Programs:

  • REMOXY® (oxycodone) Extended-Release Capsules CII.  Pfizer has efforts underway to resolve the issues raised in the REMOXY Complete Response Letter and stated in their earnings call on July 31, 2012 that they are analyzing preliminary results from two bioavailability studies and hoping to meet with the FDA in the fourth quarter.  The issues raised in the Complete Response Letter relate primarily to manufacturing.
    REMOXY, an investigational drug, is a unique long acting oral formulation of oxycodone intended to treat moderate to severe pain. Based on DURECT's ORADUR
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
    2. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
    3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    4. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
    5. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
    6. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
    7. Luminex Corporation Reports First Quarter 2012 Results
    8. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
    9. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
    10. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
    11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , Dec. 24, 2014  Novastem, a ... its first patient in its study for ischemic ... American Stroke Association, ischemic strokes account for 87 ... enroll qualified patients in the study, entitled "Internal ... of Allogeneic Mesenchymal Stem Cells and Intrathecal Administration ...
    (Date:12/24/2014)... HARRISBURG, Pa. , Dec. 24, 2014  Commonwealth Cornerstone ... New Markets Tax Credits transaction on Tuesday to help fund ... Health Network (PHN) in Sharon . ... operating in Pennsylvania . It is the ... district, with more than 150 people on staff. ...
    (Date:12/24/2014)... 2014 Kinex Pharmaceuticals announced today that the ... Park Cancer Institute. KX2-361 (KX02), a dual ... shown potent inhibitory activity against a broad panel of ... to Temozolomide (T98G), the most widely used chemotherapy for ... tumor mouse model, KX2-361 consistently clears brain tumors after ...
    Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
    ... 2011 For the second year in a row Royce ... Associates, received a supplier recognition from Carestream Health, the world,s ... Carestream Health, which supplies a complete line of Medical and ... Royce their 2010 Supplier of the Year , Carestream,s ...
    ... 2011 Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for ... update. First Quarter Financial Results ... $7.5 million, an increase of 37 percent compared with $5.4 million ... or 56 percent of net sales, compared with gross profit of ...
    Cached Medicine Technology:Royce Receives Coveted Medical Products Award 2Transgenomic Reports First Quarter Financial Results 2Transgenomic Reports First Quarter Financial Results 3Transgenomic Reports First Quarter Financial Results 4Transgenomic Reports First Quarter Financial Results 5Transgenomic Reports First Quarter Financial Results 6Transgenomic Reports First Quarter Financial Results 7Transgenomic Reports First Quarter Financial Results 8Transgenomic Reports First Quarter Financial Results 9
    (Date:12/26/2014)... California (PRWEB) December 26, 2014 Plugin and ... the TransPack Volume 5 Plugin for Final Cut Pro X. ... a hard light tool to pull off an industry professional ... users get their hands on TransPack Volume 5, a new ... 5 is a set of over 50 Final Cut Pro ...
    (Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a ... producing and marketing of a series of induction heating ... new series of induction brazing equipments . , ... induction brazing refers to the joining of two ... heat. The manager says that there are fundamental differences ...
    (Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
    (Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
    (Date:12/25/2014)... Recently, BellasDress has launched its Christmas ... BellasDress has chosen their best-selling lace wedding dresses, vintage ... holiday season. , Now, BellasDress.com features popular women’s ... at discount prices. The business hopes everyone can have ... , “All our elegant products are made with ...
    Breaking Medicine News(10 mins):Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
    ... recent increase in the number of men who are going under ... of men undergoing nip and tuck surgery has rocketed by 140 ... ,The phenomenon has been dubbed the 'menopaunch' as men fork ... to be facing pressures as women to look good thus they ...
    ... and body, a rare medical anomaly. And doctors say that laser ... ,Prithviraj Patil, son of a well-to-do farmer in Sangalwadi near ... like any normal child. ,,Prithiviraj has no problem with his ... awful - there is no itch or rash on the skin ...
    ... A type of skin cancer that was rare three decades ... the Journal of the American Medical Association (JAMA) found . ... increasingly more common in the United States in the decades ... July issue of Archives of Dermatology, which is part of ...
    ... on a teenager from wearing a so-called "purity ring" at school ... ,Lydia Playfoot, 16, said she was "disappointed" by the ruling in ... West Sussex, denies infringing her human rights, saying that the ring ... its uniform policy. ,"As a Christian I do not ...
    ... could dramatically lower the rapidly rising costs of several ... specialists suggest in a commentary in the Journal ... Mark Ratain, MD, and Ezra Cohen, MD, call attention ... certain foods can alter absorption or delay breakdown of ...
    ... is a universal problem that doctors need to ... Wake Forest University School of Medicine in ... Archives of Dermatology. ,He said non-compliance ... to treatment. ,Physicians must develop practical ...
    Cached Medicine News:Health News:Men Under Knife to Reduce Bulging Waistline in Britian 2Health News:Hairy Boy Bets on Laser Treatment for Cure 2Health News:Value Meal Would Lower Drug Costs 2Health News:Value Meal Would Lower Drug Costs 3Health News:Patients Not Complying With Their Dermatologic Problem 2Health News:Patients Not Complying With Their Dermatologic Problem 3
    ... Malaria Test is a field or laboratory test ... It is intended for the detection of circulating ... antigen that is common to all four species ... Plasmodium vivax (P.v.), Plasmodium ovale ...
    Hypervisor III Central Monitoring System...
    DS 5700 New Central Station...
    ... Alaris System integrates drug infusion,with patient ... a single, modular platform. With multiple ... modules as you,need them, keeping the ... a minimum while managing the unique ...
    Medicine Products: